Impact of anthracycline-based chemotherapy on RB1 gene methylation in peripheral blood leukocytes and biomarkers of oxidative stress and inflammation in sarcoma patients.

Autor: Pokupec Bilić, Anita, Bilić, Ivan, Radić Brkanac, Sandra, Simetić, Luka, Blažičević, Krešimir, Herceg, Davorin, Mikloš, Morana, Tonković Đurišević, Ivana, Domijan, Ana-Marija

Publikováno v: Clinical & Translational Oncology; Jun2024, Vol. 26 Issue 6, p1508-1518, 11p

Personalized Dietary Intervention Based on Mediterranean Diet as a Complementary Strategy to Modify Gut Microbiome, Quality of Life and Outcomes in Patients with Metastatic Melanoma Treated with Immunotherapy: A Study Protocol †.

Autor: Skočibušić, Nataša, Belančić, Andrej, Jovanović, Gordana Kenđel, Golčić, Marin, Herceg, Davorin, Simetić, Luka, Blažičević, Krešimir

Publikováno v: Biology & Life Sciences Forum; 2023, Vol. 29, p23, 7p

Relative Change in S100 as a Biomarker of Survival in Patients With Metastatic Melanoma Treated With Pembrolizumab

Autor: Simetić, Luka, Blažičević, Krešimir, Međugorac, Kata, Golčić, Marin, Herceg, Davorin

Publikováno v: Anticancer Research
Volume 40
Issue 4

Background/Aim: There is a lack of quality biomarkers of survival for patients with metastatic melanoma treated with immunotherapy. Although the baseline level of S100 has prognostic value, its role during/after therapy in survival is unclear. Patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8b33e9b9d54a6c1f6a0e838787da3aea
https://repository.medri.uniri.hr/islandora/object/medri:5692

SARKOMI S CIC-PREUREDBOM GENA: PRIKAZ SERIJE SLUČAJEVA. (Croatian)

Autor: VRBANEC, JURICA, Kelečić, Ana, Herceg, Davorin, Blažičević, Krešimir, Breški, Anita, Dotlić, Snježana, Milavić, Marija, Simetić, Luka

Publikováno v: Lijecnicki Vjesnik; 2023 Supplement, Vol. 145, p52-53, 2p

Relative Change in S100 as a Biomarker of Survival in Patients With Metastatic Melanoma Treated With Pembrolizumab.

Autor: Simetić L; Clinical Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia., Blažičević K; Clinical Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia., Međugorac K; Clinical Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia., Golčić M; Clinical Hospital Centre Rijeka, Department of Radiotherapy and Oncology, Rijeka, Croatia., Herceg D; Clinical Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia davorinh1@gmail.com.

Publikováno v: Anticancer research [Anticancer Res] 2020 Apr; Vol. 40 (4), pp. 2157-2163.